STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: On 14 January 2009, Vitrolife AB (publ) (“Vitrolife”) (STO:VITR) announced its intention to make a voluntary offer to the shareholders of MediCult a/s (“MediCult”) to acquire all outstanding shares in MediCult for consideration in the form of new shares in Vitrolife (the “Offer”).
